Product Program year 2025 Source: CMS Open Payments

General - Therapies

Device General - Therapies_PI

Open in the dashboard

General payments

$17,100,727

4,158 payments

Research payments

$0

0 payments

Through program year 2025, $17,100,727 in general payments and $0 in research payments were reported against General - Therapies (General - Therapies_PI).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $16,070,482 2,495
2022 General $950,601 1,633
2021 General $79,644 30

Breakdown

Who paid General payments · program years 2021–2025
  1. Boston Scientific Corporation $17,100,727 4,158 payments
Top recipients General payments · program year 2025
  1. David Dove Internal Medicine · East Hampton, NY $12,257,629 76% · 2 payments
  2. Matthew Price Interventional Cardiology · La Jolla, CA $1,087,385 7% · 1 payment
  3. Ajay Kirtane Interventional Cardiology · New York, NY $263,090 2% · 1 payment
  4. Mohamed Azeem Latib Interventional Cardiology · Bronx, NY $263,050 2% · 1 payment
  5. Mitul Patel Interventional Cardiology · San Diego, CA $210,432 1% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Internal Medicine $12,353,064 77% · 10 practitioners
  2. Interventional Cardiology Internal Medicine $2,282,111 14% · 66 practitioners
  3. Vascular Surgery Surgery $620,185 4% · 135 practitioners
  4. Vascular & Interventional Radiology Radiology $448,390 3% · 97 practitioners
  5. Diagnostic Radiology Radiology $104,466 <1% · 34 practitioners

The top 5 of 39 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $13,080,176 81% · 32 recipients
  2. California $1,509,573 9% · 62 recipients
  3. Texas $121,715 <1% · 28 recipients
  4. Pennsylvania $111,230 <1% · 22 recipients
  5. Kentucky $108,383 <1% · 4 recipients

The top 5 of 46 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

4,158 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record